Efforts to Improve the Seasonal Influenza Vaccine

Seasonal influenza is an acute syndrome, principally involving the respiratory tract caused by influenza viruses that are globally present [...].

• Publication year

  2020

• Venue

  Vaccines

• Publication date

  2020-11-03

• Fields of study

  Medicine

• Identifiers
  DOI 10.3390/vaccines8040645PMID 33153011PMCID 7712773
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Next-generation influenza vaccines: opportunities and challenges

  2020influential reference
• Influenza vaccine effectiveness in inpatient and outpatient settings in the United States, 2015 - 2018.

  2020cited by this paper
• Influenza vaccination in the COVID-19 era

  2020cited by this paper
• Influenza in the COVID-19 Era.

  2020cited by this paper
• Adenoviral Vector-Based Vaccine Platforms for Developing the Next Generation of Influenza Vaccines

  2020cited by this paper
• Next Generation Influenza Vaccines: Looking into the Crystal Ball

  2020cited by this paper
• The Impact of the Microbiome on Immunity to Vaccination in Humans

  2020cited by this paper
• A real-world study evaluating the relative vaccine effectiveness of a cell-based quadrivalent influenza vaccine compared to egg-based quadrivalent influenza vaccine in the US during the 2017-18 influenza season.

  2020cited by this paper
• New Points of Departure for More Global Influenza Vaccine Use

  2020cited by this paper
• Prospects and Challenges in the Development of Universal Influenza Vaccines

  2020cited by this paper
• The Effect of Influenza Vaccination for the Elderly on Hospitalization and Mortality

  2020cited by this paper
• Host Factors Impact Vaccine Efficacy: Implications for Seasonal and Universal Influenza Vaccine Programs

  2019cited by this paper
• Oseltamivir plus usual care versus usual care for influenza-like illness in primary care: an open-label, pragmatic, randomised controlled trial.

  2019cited by this paper
• Role of the Microbiota in the Modulation of Vaccine Immune Responses

  2019cited by this paper
• Effectiveness of four types of neuraminidase inhibitors approved in Japan for the treatment of influenza

  2019cited by this paper
• Effectiveness of the trivalent MF59 adjuvated influenza vaccine in preventing hospitalization due to influenza B and A(H1N1)pdm09 viruses in the elderly in Italy, 2017 – 2018 season

  2019cited by this paper
• Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial

  2019cited by this paper
• Efforts to Improve the Seasonal Influenza Vaccine

  2018cited by this paper
• How far have we reached in development of effective influenza vaccine?

  2018cited by this paper
• Influenza Virus: Dealing with a Drifting and Shifting Pathogen

  2018cited by this paper
• A Universal Influenza Vaccine: The Strategic Plan for the National Institute of Allergy and Infectious Diseases

  2018cited by this paper
• Rationally Designed Influenza Virus Vaccines That Are Antigenically Stable during Growth in Eggs

  2017cited by this paper
• The 2015 global production capacity of seasonal and pandemic influenza vaccine

  2016cited by this paper
• Current and next generation influenza vaccines: Formulation and production strategies.

  2015cited by this paper
• Formulation of influenza T cell peptides : in search of a universal influenza vaccine

  2015cited by this paper
• Cell culture-based influenza vaccines: A necessary and indispensable investment for the future

  2015cited by this paper
• Technology transfer and scale-up of the Flublok recombinant hemagglutinin (HA) influenza vaccine manufacturing process.

  2014cited by this paper
• Influenza T-cell Epitope-Loaded Virosomes Adjuvanted with CpG as a Potential Influenza Vaccine

  2014cited by this paper
• Traditional and New Influenza Vaccines

  2013cited by this paper
• The history of MF59® adjuvant: a phoenix that arose from the ashes

  2013cited by this paper
• Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies

  2013cited by this paper
• Influenza A vaccines using linear expression cassettes delivered via electroporation afford full protection against challenge in a mouse model.

  2012cited by this paper
• Influenza, Seasonal

  2011cited by this paper
• Influenza virus: a master of metamorphosis.

  2000cited by this paper
• Looking into the Crystal Ball

  1982cited by this paper

• Seasonal Influenza: A Narrative Review of Epidemiology, Clinical Features, and Preventive Strategies

  2025cites this paper
• Discovery of Potent and Efficacious Influenza PB2 Inhibitors.

  2025cites this paper
• Impact of host genetic polymorphisms on response to inactivated influenza vaccine in children

  2023cites this paper
• mRNA vaccines encoding influenza virus hemagglutinin (HA) elicits immunity in mice from influenza A virus challenge

  2023cites this paper
• Estimation of Reduction in Influenza Vaccine Effectiveness Due to Egg-Adaptation Changes—Systematic Literature Review and Expert Consensus

  2021cites this paper
• Hotspots for mutations in the SARS-CoV-2 spike glycoprotein: a correspondence analysis

  2021cites this paper